Skip to main content
SpringerLink
Log in

Contraception and Cardiovascular Diseases

  • Chapter
  • First Online:
Female and Male Contraception

Part of the book series: Trends in Andrology and Sexual Medicine ((TASM))

  • 1216 Accesses

Abstract

Women during reproductive years, who need safe contraception, can suffer from many different cardiovascular diseases. This is a comprehensive review about the possible use of different modern contraceptives (intrauterine devices, progestogen-only contraceptives, combined hormonal contraceptives) in women with cardiovascular diseases, such as hypertension, dyslipidaemia, valvular heart disease or arrhythmia or with history of high blood pressure during pregnancy, ischaemic heart disease, cerebrovascular accident or deep-vein thrombosis according to most updated International Guidelines. The main aim of this chapter is to suggest to the clinician when the theoretical or proven risks due to the disease outweigh the advantages of using a method of contraception, in order to avoid unsuitable prescriptions and serious adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ACOG:

American College of Obstetricians and Gynaecologists

AF:

Atrial Fibrillation

AHA:

American Heart Association

AMI:

Acute Myocardial Infarction

AT:

Antithrombin

BP:

Blood Pressure

C:

Continuation

CHC:

Combined Hormonal Contraception

CHD:

Coronary Heart Disease

COC:

Combined Oral Contraception

Cu-IUD:

Copper-Intrauterine Device

CVD:

Cardiovascular Disease

CVR:

Combined Vaginal Ring

DMPA:

Progestogen-only injectable: depot medroxyprogesterone acetate

DVT:

Deep Vein Thrombosis

EPT:

Oestrogen Plus Therapy

ET:

Oestrogen alone Therapy

HDL:

High Density Lipoproteins

HRT:

Hormone Replace Therapy

I:

Initiation

ICH:

Intracerebral Haemorrhage

IMP:

Progestogen-only Implant

IUD:

Intrauterine Device

LDL:

Low Density Lipoproteins

LNG-IUS:

Levonorgestrel-Intrauterine System

MEC:

Medical Eligibility Criteria

MI:

Myocardial Infarction

MTHFR:

Methylene Tetrahydrofolate Reductase

NSTEMI:

Non-ST elevation Myocardial Infarction

P:

Transdermal Patch

PE:

Pulmonary Embolism

POC:

Progestogen-only Contraception

POP:

Progestogen-only pill

SAH:

Subarachnoid Haemorrhage

STEMI:

ST elevation Myocardial Infarction

TG:

Triglycerides

TIA:

Transient Ischemic Attack

TOAST:

Trial of Org 10,172 in Acute Stroke Treatment

UKMEC:

UK Medical Eligibility Criteria

USCDC:

US Medical Eligibility Criteria

VHD:

Valvular Heart Disease

VLDL:

Very Low-Density Lipoproteins

VTE:

Venous Thromboembolism

WHO:

Wold Health Organization

References

  1. UK medical eligibility criteria for contraceptive use. UKMEC 2016.

    Google Scholar 

  2. U.S. Medical Eligibility Criteria for Contraceptive Use, USCDC, 2016.

    Google Scholar 

  3. Medical eligibility criteria for contraceptive use, 5th ed., 2015, World Health Organization, 2015.

    Google Scholar 

  4. National Institute for Health and Care Excellence (NICE). Hypertension in Adults: Diagnosis and Management, 2011.

    Google Scholar 

  5. Poulter NR, Chang CL, Farley TM, et al. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet. 1997;349:1202–9.

    Article  Google Scholar 

  6. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Contraception. 1998;57:315–24.

    Article  Google Scholar 

  7. Gillum LA, Mamidipudi SK, Johnston SC. Ischaemic stroke risk with oral contraceptives: a meta-analysis. JAMA. 2000;284:72–8.

    Article  CAS  PubMed  Google Scholar 

  8. Khader YS, Rice J, John L, et al. Oral contraceptive use and the risk of myocardial infarction: a meta-analysis. Contraception. 2003;68:11–7.

    Article  CAS  PubMed  Google Scholar 

  9. Nightingale AL, Lawrenson RA, Simpson EL, et al. The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives. Eur J Contracept Reprod Health Care. 2000;5:265–74.

    Article  CAS  PubMed  Google Scholar 

  10. Tanis BC, van den Bosch MA, Kemmeren JM, et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med. 2001;345:1787–93.

    Article  CAS  PubMed  Google Scholar 

  11. van den Bosch MA, Kemmeren JM, Tanis BC, et al. The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. J Thromb Haemost. 2003;1:439–44.

    Article  Google Scholar 

  12. Poulter NR, Chang CL, Farley T, et al. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1995;346:1575–82.

    Article  Google Scholar 

  13. Heinemann LAJ, Lewis MA, Spitzer WO, et al. Thromboembolic stroke in young women. A European casecontrol study on oral contraceptives. Contraception. 1998;57:29–37.

    Article  CAS  PubMed  Google Scholar 

  14. Lewis MA, Heinmann LAJ, Spitzer WO, et al. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the transnational study on oral contraceptives and the health of young women. Contraception. 1997;56:129–40.

    Article  CAS  PubMed  Google Scholar 

  15. Poulter NR, Chang CL, Farley TM, et al. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. Int J Gynecol Obstet. 1997;1:103.

    Google Scholar 

  16. Poulter NR, Chang CL, Farley TM, et al. Ischaemic stroke and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1996;348:498–505.

    Article  Google Scholar 

  17. Task Force of the American Medical Association. Oral contraceptives and stroke in young women. Associated risk factors. JAMA. 1975;231:718–22.

    Article  Google Scholar 

  18. Croft P, Hannaford P. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners’ Oral Contraception Study. BMJ. 1989;298:165–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. D’Avanzo B, La Vecchia C, Negri E, et al. Oral contraceptive use and risk of myocardial infarction: an Italian case-control study. J Epidemiol Community Health. 1994;48:324–8.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Dunn NR, Faragher B, Thorogood M, et al. Risk of myocardial infarction in young female smokers. Heart. 1999;82:581–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Hannaford P, Croft P, Kay CR. Oral contraception and stroke: evidence from the Royal College of General Practitioners’ Oral Contraception Study. Stroke. 1994;25:935–42.

    Article  CAS  PubMed  Google Scholar 

  22. Kemmeren JM, Tanis BC, van den Bosch MA, et al. Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischaemic stroke. Stroke. 2002;33:12021208.

    Article  Google Scholar 

  23. Lidegaard Ø. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. BMJ. 1993;306:956–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Lidegaard Ø. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. BJOG. 1995;102:153–9.

    Article  CAS  Google Scholar 

  25. Lubianca JN, Faccin CS, Fuchs FD. Oral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive women. Contraception. 2003;67:19–24.

    Article  CAS  PubMed  Google Scholar 

  26. Narkiewicz K, Grabiero GR, d’Este D, et al. Ambulatory blood pressure in mild hypertensive women taking oral contraceptives. A case-control study. Am J Hypertens. 1995;8:249–53.

    Article  CAS  PubMed  Google Scholar 

  27. Siritho S, Thrist AG, McNeil JJ, et al. Risk of ischaemic stroke among users of the oral contraceptive pill: The Melbourne Risk Factor Study (MERFS) Group. Stroke. 2003;34:1575–80.

    Article  PubMed  Google Scholar 

  28. Lubianca JN, Moreira LB, Gus M, et al. Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension. J Hum Hypertens. 2005;19:451–5.

    Article  CAS  PubMed  Google Scholar 

  29. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet. 1997;349:1202–9.

    Article  Google Scholar 

  30. WHO. Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet. 1996;348:505–10.

    Article  Google Scholar 

  31. Aberg H, Karlsson L, Melander S. Studies on toxaemia of pregnancy with special reference to blood pressure. ll. Results after 6–11 years’ follow-up. Ups J Med Sci. 1978;83:97–102.

    Article  CAS  PubMed  Google Scholar 

  32. Carmichael SM, Taylor MM, Ayers CR. Oral contraceptives, hypertension, and toxemia. Obstet Gynecol. 1970;35:371–6.

    CAS  PubMed  Google Scholar 

  33. Meinel H, Ihle R, Laschinski M. Effect of hormonal contraceptives on blood pressure following pregnancyinduced hypertension [in German]. Zentralbl Gynakol. 1987;109:527–31.

    CAS  PubMed  Google Scholar 

  34. Pritchard JA, Pritchard SA. Blood pressure response to estrogen-progestin oral contraceptive after pregnancy-induced hypertension. Am J Obstet Gynecol. 1977;129:733–9.

    Article  CAS  PubMed  Google Scholar 

  35. Sibai BM, Taslimi MM, El-Nazer, et al. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Obstet Gynecol. 1986;155:501–9.

    CAS  Google Scholar 

  36. Sibai BM, Ramadan MK, Chri RS, et al. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol. 1995;172:125–9.

    Article  CAS  PubMed  Google Scholar 

  37. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet. 1995;346:1575–82.

    Article  Google Scholar 

  38. WHO Collaborative Study of Cardiovascular disease and Steroid Hormone Contraception. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet. 1996;348:498–505.

    Article  Google Scholar 

  39. de Bruijn SF, Stam J, Koopman MM, et al. Case-control study of risk of cerebral sinu thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. BMJ. 1998;316:589–92.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Caplan LR. Basic pathology, anatomy, and pathophysiology of stroke. In: Caplan's stroke: a clinical approach. 4th ed. Philadelphia: Saunders Elsevier; 2009. p. 22.

    Chapter  Google Scholar 

  41. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. 3rd Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41.

    Article  PubMed  Google Scholar 

  42. Gronich N, Lavi I, Rennert G. Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study. CMAJ. 2011;183(18):E1319–25. 43

    Article  PubMed  PubMed Central  Google Scholar 

  43. Runnebaum B, Grunwald K, Rabe T. The efficacy and tolerability of norgestimate/ethinyl estradiol (250 micrograms of norgestimate/35 micrograms of ethinyl estradiol): results of an open, multicenter study of 59,701 women. Am J Obstet Gynecol. 1992;166:1963–8.

    Article  CAS  PubMed  Google Scholar 

  44. Iung B, Vahanian A. Epidemiology of Acquired Valvular Heart Disease. Cardiology Department, Bichat Hospital, and Paris 7 Diderot University, Paris, France.

    Google Scholar 

  45. FSRH Guidance (2014) Contraceptive Choices for Women with Cardiac Disease (Revision due by June 2019).

    Google Scholar 

  46. National Institute for Health and Care Excellence (NICE) (2008) Prophylaxis Against Infective Endocarditis: Antimicrobial Prophylaxis Against Infective Endocarditis in Adults and Children Undergoing Interventional Procedures.

    Google Scholar 

  47. Faculty of Family Planning & Reproductive Health. UK Selected practice recommendations for contraceptive use, 2002.

    Google Scholar 

  48. Sedlak T, Shufelt C, Iribarren C, et al. Sex hormones and the QT interval: a review. J Womens Health (Larchmt). 2012;21(9):933–41.

    Article  Google Scholar 

  49. Altunkeser BB, Ozdemir K, Icli A, et al. Effects of long-term hormone replacement therapy on QT and corrected QT dispersion during resting and peak exercise electrocardiography in post-menopausal women. Jpn Heart J. 2002;43(1):1–7.

    Article  CAS  PubMed  Google Scholar 

  50. Grandi G, Xholli A, Napolitano A, et al. Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol. Contraception. 2014;90(5):529–34.

    Article  CAS  PubMed  Google Scholar 

  51. Camm AJ, Kirchhof P, Lip GY, et al. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369–429.

    Article  PubMed  Google Scholar 

  52. Camm AJ, Lip GY, De Caterina R, et al. Guidelines ESCCF P. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed wi.th the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719–47.

    PubMed  Google Scholar 

  53. Van Vlijmen EF, Veeger NJ, Middeldorp S, et al. The impact of a male or female thrombotic family history on contraceptive counseling: a cohort study. J Thromb Haemost. 2016;14(9):1741–8.

    Article  PubMed  Google Scholar 

  54. Tromeur C, Le Mao R, Jego P, et al. Risk factors for thromboembolic disease in young women-the role of hormones. Rev Mal Respir. 2019;36(2):219–26.

    Article  CAS  PubMed  Google Scholar 

  55. Martinez F, Avecilla A. Combined hormonal contraception and venous thromboembolism. Eur J Contracept Reprod Health Care. 2007;12(2):97–106.

    Article  CAS  PubMed  Google Scholar 

  56. Dinger J, Do Minh T, Heinemann K. Impact of estrogen type on cardiovascular safety of combined oral contraceptives. Contraception. 2016;94(4):328–39.

    Article  CAS  PubMed  Google Scholar 

  57. Noboa S, Le G, Lacut K, et al. Family history as a risk factor for venous thromboembolism. Thromb Res. 2008;122:624–9.

    Article  CAS  PubMed  Google Scholar 

  58. Rott H. Thrombotic risks of oral contraceptives. Curr Opin Obstet Gynecol. 2012;24(4):235–40.

    Article  PubMed  Google Scholar 

  59. Mohllajee AP, Curtis KM, Martins SL, et al. Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review. Contraception. 2006;73(2):166–78.

    Article  CAS  PubMed  Google Scholar 

  60. Sykes TC, Fegan C, Mosquera D. Thrombophilia, polymorphisms, and vascular disease. Mol Pathol. 2000;53(6):300–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Gindele R, Selmeczi A, Oláh Z, et al. Clinical and laboratory characteristics of antithrombin deficiencies: a large cohort study from a single diagnostic center. Thrombosis Res. 2017;160:119–28.

    Article  CAS  Google Scholar 

  62. Vrtěl P, Slavík L, Vodička R, et al. Searching for genetic variants associated with thrombophilia. Cas Lek Cesk. 2019;158(1):28–32.

    PubMed  Google Scholar 

  63. J O'Donnella C, Elosua R. Cardiovascular risk factors. insights from Framingham Heart Study. Rev Esp Cardiol. 2008;61(3):299–310.

    Article  Google Scholar 

  64. Grundy SM, Pasternak R, Greenland P, et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology. Circulation. 1999;100:1481–92.

    Article  CAS  PubMed  Google Scholar 

  65. Wilson PW, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.

    Article  CAS  PubMed  Google Scholar 

  66. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79(1):8–15.

    Article  CAS  PubMed  Google Scholar 

  67. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345(18):1291–7.

    Article  CAS  PubMed  Google Scholar 

  68. Messner B, Bernhard D. Smoking and cardiovascular disease. Mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 2014;34:509–15.

    Article  CAS  PubMed  Google Scholar 

  69. Goldschmid MG, Barrett-Connor E, Edelstein SL, et al. Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. Circulation. 1994;89(3):991–7.

    Article  CAS  PubMed  Google Scholar 

  70. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA. 1987;257(16):2176–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero Universitaria Policlinico, Modena, Italy

    Maria Chiara Del Savio, Margaret Sammarini, Fabio Facchinetti & Giovanni Grandi

Authors
  1. Maria Chiara Del Savio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Margaret Sammarini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fabio Facchinetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giovanni Grandi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Grandi .

Editor information

Editors and Affiliations

  1. Department of Medical and Surgical Science, University of Bologna, Clinic of Gynecology and Physiopathology of Reproduction, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

    Maria Cristina Meriggiola

  2. Department of Women’s and Children’s Health, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden

    Kristina Gemzell-Danielsson

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Del Savio, M.C., Sammarini, M., Facchinetti, F., Grandi, G. (2021). Contraception and Cardiovascular Diseases. In: Meriggiola, M.C., Gemzell-Danielsson, K. (eds) Female and Male Contraception. Trends in Andrology and Sexual Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-70932-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-70932-7_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-70931-0

  • Online ISBN: 978-3-030-70932-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation